Der-Chi Tien

Title: **Der-Chi Tien: Pioneering Innovations in Pharmaceutical Compositions**

Introduction

Der-Chi Tien is a notable inventor based in Taoyuan County, Taiwan. With a focus on innovative pharmaceutical compositions, Tien holds two patents that demonstrate his commitment to advancing medical technology.

Latest Patents

Among Der-Chi Tien's recent innovations is the patent for a "Radiolabeled Active Targeting Pharmaceutical Composition and the Use Thereof." This groundbreaking invention includes a bioconjugate and a radionuclide, where the bioconjugate consists of a biomolecule and a metal nanoparticle. The biomolecule demonstrates an affinity for cell membrane receptors and is selected from peptides and proteins. This patent also encompasses a method for evaluating thermal adjuvant therapy for tumors and a corresponding kit. The aforementioned composition is utilized to assess tumor accumulation time, aiding in the formulation of the optimal strategy for radiofrequency or laser-induced thermal therapies for tumors.

Career Highlights

Der-Chi Tien has contributed significantly to his field through his association with reputable institutions such as the Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, and National Yang-Ming University. His experience in these organizations has played a crucial role in his development as an inventor and researcher.

Collaborations

Throughout his career, Tien has collaborated with esteemed colleagues including Hsin-Ell Wang and Chien-Chung Hsia. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the pharmaceutical sector.

Conclusion

Der-Chi Tien's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his status as a prominent inventor. His work not only advances therapeutic techniques for tumors but also exemplifies the potential of targeted pharmaceutical compositions in medical applications.